• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

6/2/2007 Mid-Cycle Review - Chemistry, Manufacturing, Controls - RECOTHROM

M E M O R A N D U M

Department of Health and Human Services
Public Health Service
Food and Drug Administration
Center for Biologics Evaluation and Research

Date: June 12, 2007
To: File
From: Nancy Kirschbaum
Subject: Mid-cycle review memo, STN 125248: Thrombin, Topical (Recombinant), ZymoGenetics, Inc. Original BLA, Chemistry, Manufacturing, and Controls
CC: Roman Drews
Tim Lee
Mark Shields
Nisha Jain
Nancy Waites

Drug Substance
3.2.S.1.2; 3.2.S.1.3 Structure and General Properties-

--------------   -------------------------------------------------------------------

-------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------

--------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------
---------------

  • ------------------------------------------------------------
  • ------------------------------------------------------------------------
  • ----------------------------------------------------------------------

-----------------------------------------------------


18


PAGE(S)


DETERMINED


TO BE


NOT RELEASABLE

 

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002